EUCRATES BIOMEDICAL ACQU COR (EUCR)
Institutional ownership reported to the SEC as of Q1 2023, across 10 quarters.
4
Reporting holders
$2.3M
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | $2.0M | 200,000 | 0.07% | 9q | HELD |
| DEUTSCHE BANK AG\ | $222.3K | 21,923 | 0.00% | 2q | HELD |
| SkyView Investment Advisors, LLC | $728 | 71,773 | 0.17% | 7q | HELD |
| Tower Research Capital LLC (TRC) | $7 | 647 | 0.00% | 4q | -1.5% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 4 | $2.3M | 294,343 | 0 | 0 | 1 | 0.0% |
| Q4 2022 | 3 | $2.3M | 225,406 | 1 | 0 | 1 | 0.0% |
| Q3 2022 | 37 | $84.5M | 8,434,719 | 5 | 6 | 3 | 0.0% |
| Q2 2022 | 37 | $76.7M | 7,746,919 | 3 | 11 | 4 | 0.0% |
| Q1 2022 | 39 | $73.2M | 7,435,324 | 4 | 13 | 4 | 0.0% |
| Q4 2021 | 39 | $64.6M | 6,619,370 | 10 | 7 | 4 | 0.0% |
| Q3 2021 | 34 | $50.1M | 5,118,549 | 6 | 5 | 5 | 0.0% |
| Q2 2021 | 31 | $47.9M | 4,863,023 | 12 | 5 | 3 | 0.0% |
| Q1 2021 | 20 | $41.8M | 4,195,714 | 15 | 1 | 2 | 0.0% |
| Q4 2020 | 5 | $13.9M | 1,385,690 | 5 | 0 | 0 | 0.0% |